ArticleOncoTargets and therapy2021

Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells.

Mei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.